Volume 1, Issue 4 (Multidisciplinary Cancer Investigation 2017)                   Multidiscip Cancer Investig 2017, 1(4): 1-6 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

jafari M, Olfatbakhsh A, rezaei-kalantari K. Male Breast Cancer; A Review of Risk Factors and Clinical and Radiological Features. Multidiscip Cancer Investig 2017; 1 (4) :1-6
URL: http://mcijournal.com/article-1-66-en.html
1- Breast Diseases Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran , maryjafaimd@gmail.com
2- Breast Diseases Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
3- Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
Abstract:   (7936 Views)

While male breast cancer (MBC) consists only 1% of all breast cancers in the United States, approximately 2000 men are diagnosed annually and the incidence seems to be slowly increasing. About 50% of men have axillary nodal metastasis at the time of diagnosis. A mean delay of 6 to 10 months occurs in the diagnosis of MBC, which leads to the progression of the disease before presentation. More than 40% of MBCs presen with stage III/IV disease. Therefore, men with MBC have a worse prognosis compared with women. Additionally, as a result of the paucity of breast tissue in males, early chest wall spread occurs. Therefore, it seems that recognition of the symptoms and radiologic features of MBC can improve early detection, the prognosis and survival rate of the disease. A few researches focused on male breast cancer; however, there are many similarities with female breast cancer and some differences. The current study aimed to review the latest information on risk factors, clinical, and radiological features of MBC.

Full-Text [PDF 514 kb]   (4585 Downloads)    
Select article type: Review Article | Subject: Supportive and Palliative Care
Received: 2017/08/2 | Accepted: 2017/09/20 | ePublished: 2017/10/1

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Multidisciplinary Cancer Investigation

Designed & Developed by : Yektaweb